Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2012-03-16

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2012-03-09

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2012-03-09

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2012-03-09

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2012-03-08

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2012-03-08

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2012-03-08

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2012-03-05

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2012-03-05

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2012-02-29

View Filing